The OncFive: Top Oncology Articles for the Week of 5/11
Summary by onclive.com
4 Articles
4 Articles
All
Left
Center
Right
Incyte’s Zynyz receives FDA approval for anal cancer treatment
WILMINGTON — Incyte, one of Delaware’s top pharmaceutical companies, has secured U.S. Food and Drug Administration (FDA) approval to use Zynyz as a treatment for anal cancer. Zynyz, an intravenous PD-1 inhibitor, may now be used in combination with platinum-based chemotherapy as well as a monotherapy for metastatic squamous cell carcinoma (SCAC), which makes up [...]
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage